Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Ery... (R 2009 showed that continued treatment w...)

HOME >> BIOLOGY >> TECHNOLOGY

Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus

Date:6/11/2009

R 2009 showed that continued treatment with belimumab (BENLYSTA) is associated with sustained improvement or stabilization of SLE disease activity and with decreased frequency of SLE disease flares in serologically active patients through four years of treatment. The overall incidence of adverse events (in general and by system organ class), serious adverse events, infections, malignancies and laboratory abnormalities decreased or stabilized over time from Week 52 to Week 208.

The evidence of sustained clinical effect from Week 52 to Week 208 in serologically active patients who were treated with belimumab from initiation of the Phase 2 study includes:

An increase from 46% to 57% in the response rate selected as the primary efficacy endpoint of the Phase 3 trials (defined by an improvement in SELENA SLEDAI score of 4 points or greater, no BILAG worsening, and no worsening in Physician's Global Assessment; post hoc; intention-to-treat analysis).
A decrease from 62% to 16% in the overall frequency of SLE disease flares, and from 8% to 1% in the frequency of severe disease flares, as measured by the SELENA SLEDAI Flare Index.
A decrease from 23% to 5% in the frequency of patients experiencing one new BILAG A organ domain score (which would indicate a severe flare of lupus disease activity) or more than one new BILAG B organ domain score (which would indicate a moderate flare of disease activity).

The data presented at EULAR 2009 suggest that belimumab was generally well tolerated and may be safely administered long-term in patients with SLE. By Week 208, overall belimumab exposure was 1192 patient years. The incidence rates per 100 patients in all adverse event categories, including serious adverse events, overall adverse events, and serious infections, were similar for belimumab and placebo during the 52-week double-blind period, a
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8
Related biology technology :

1. Printing New Organs: Foundation Funds Medical Technology That Replicates Human Tissue
2. New MIT radio chip mimics human ear
3. deCODE Study Shows Complex Interplay of the Human Biological Clock With Height, Weight and Disease
4. Human Genome Sciences and Novozymes Announce Amendment to Albumin Fusion License Agreement
5. Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments
6. FDA has Granted HUD (Humanitarian Use Device) Designation to ITGIs Pericardium Covered Stents, Over and Under(R) and Aneugraft(R), for Treatment of Perforations and Dissections of Native Coronary Arteries and Saphenous Vein Grafts
7. STEMCELL Technologies Introduces a New Animal Component-Free, Serum-Free Medium for Culturing Human Mesenchymal Stem Cells
8. CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease
9. Human Genome Sciences to Sponsor Conference Call to Discuss First Quarter 2009 Financial Results
10. The Journal of Cardiac Failure Publishes Results From Celladon Corporations First-in-Human Phase 1/2 Clinical Trial in Advanced Heart Failure
11. ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Mesenchymal Cells

Post Your Comments:

(Date:6/18/2013)... 2013 China Cord Blood Corporation (NYSE: ... provider of cord blood collection, laboratory testing, hematopoietic stem ... its preliminary unaudited financial results for the fourth quarter ... 31, 2013. Fourth Quarter of Fiscal ... of fiscal 2013 increased by 33.3% to RMB133.0 million ...

(Date:6/18/2013)... 2013 In support of Swiss contributions ... General of Switzerland in New York is pleased to ... Tûranor PlanetSolar , to Manhattan. PlanetSolar is in ... 2013 tour with scientists on board from the University ... runs exclusively on energy from the sun and eliminates ...

(Date:6/18/2013)... 2013 (PRWEB) June 18, 2013 ... system in North America, has introduced AccountLinx Plus, ... and payroll records between ExakTime’s software and industry-leading ... ExakTime software setup and keeps employee databases up-to-date ... from a business’ current payroll software, directly into ...

(Date:6/18/2013)... 18, 2013 The Regulatory Affairs ... two new offices in Asia—one in Singapore and one ... as RAPS’ Pan-Asia office , serving the Asia ... focused on audiences within China. , The announcement comes ... with five Singapore government agencies to develop and implement ...

[0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 [0] Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City [0] ExakTime Introduces AccountLinx Plus [0] RAPS Opens Offices in Singapore and China

... ORLANDO, Fla. , May 11 GeneLink, Inc. (OTC Bulletin ... quarter ended March 31, 2010 . , , ... , , , ... Quarterly operating loss reduced by 14% over Q4 2009 Comparable quarter gross profit improvement ...

... LONDON , May 11, 2010 The subject ... point in the,scientific community. And as evidence comes to light of the continuing,beneficial ... UK has confirmed what many scientists already believe to,be the case - that ... , , , ...

... , May 11 EnVivo Pharmaceuticals today ... Phase IIb study of its EVP-6124 compound, a selective ... Alzheimer,s disease. The multi-center, dose ranging, placebo controlled, six-month ... is designed to determine the safety and efficacy ...

Cached Biology Technology:GeneLink Reports First Quarter Gains 2 Can Resveratrol Make You Smarter? 2 Can Resveratrol Make You Smarter? 3 Can Resveratrol Make You Smarter? 4 Can Resveratrol Make You Smarter? 5 EnVivo Initiates Phase IIb Alzheimer's Disease Trial For EVP-6124 2 EnVivo Initiates Phase IIb Alzheimer's Disease Trial For EVP-6124 3

GeneLink Reports First Quarter Gains Can Resveratrol Make You Smarter?EnVivo Initiates Phase IIb Alzheimer's Disease Trial For EVP-6124

(Date:6/18/2013)... of Calgary,s Faculty of Medicine have discovered a mechanism ... bacteria. Platelets, a component of blood typically associated with ... and upon detection, seal it off from the rest ... Nature Immunology this week, provide the science ... science community has known that platelets do participate in ...

(Date:6/18/2013)... United Kingdom, the Energy Department,s National Renewable Energy ... recently published a paper describing a novel cellulose-degrading ... quadripunctata , commonly known as the gribble. ... a relatively unique ability to produce their own ... down the biomass they eat. New biomass-degrading enzymes ...

(Date:6/18/2013)... UT Arlington environmental engineer has been awarded a ... to ensure water quality and flow in the ... , Andrew Kruzic, UT Arlington associate professor of ... locations to add monochloramine to the water in ... new pump stations and pipelines. Adding monochloramine is ...

Breaking Biology News(10 mins):Immunity mechanism discovered 2 Novel enzyme from tiny gribble could prove a boon for biofuels research 2 UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2

[0] Immunity mechanism discovered [0] Novel enzyme from tiny gribble could prove a boon for biofuels research [0] UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline

... SAN FRANCISCO, CAOctober 10, 2010Scientists at the Gladstone Institute ... associated with the storage of fat in the liver is ... (HCV). This discovery may offer a new strategy for treating ... throughout the world, and no vaccine is available to prevent ...

... The soils in large areas of the Southern Hemisphere, including ... drying up in the past decade, a group of researchers ... on a global basis. Most climate models have suggested ... land to the atmosphere, would increase with global warming. The ...

... on the way for millions of people on the East ... have reported a key advance in efforts to develop the ... major nuisance to homeowners and a devastating pest to some ... that infects a common weed and found that it shows ...

Cached Biology News:Gladstone scientists link hepatitis C virus infection to fat enzyme in liver cells 2 Land 'evapotranspiration' taking unexpected turn: huge parts of world are drying up 2 Land 'evapotranspiration' taking unexpected turn: huge parts of world are drying up 3 Progress toward first commercial repellent for East Coast's stinker 2

Gladstone scientists link hepatitis C virus infection to fat enzyme in liver cells Land 'evapotranspiration' taking unexpected turn: huge parts of world are drying up Progress toward first commercial repellent for East Coast's stinker

...

... high PCR specificity *High PCR specificity ... enzyme with unique QIAGEN PCR Buffer ... provided by the stringent built-in hot ... Master Mix and simple reaction setup ...

... (NMPs) make up the internal structural framework of ... as DNA replication, RNA synthesis, and hormone receptor ... to be highly insoluble in vitro , ... soluble nuclear matrix proteins that can be detected ...

Request Info...

Biology Products:

Angiotensin Converting Enzyme Colorimetric Assay Kit from Alpco Diagnostics Hot StarTaq Master Mix Kit from QIAGEN Nuclear Matrix Protein ELISA Kit from Calbiochem T4 DNA Polymerase from Roche Applied Science